ARCHIVES

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

This article is from The Cancer Letter archive.

Vol. 13 No. 02 | January 9, 1987

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

NCI To Implement Recommendations, Sondik Says

September 2, 1988

New Subcommittee Chairman Named

June 10, 1977

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Post Starts Series With Horror Stories On Drug Testing; DeVita Says They Are “Slanted, Distorted”

October 23, 1981